IT1392395B1 - COMPOSITIONS FOR PREVENTION AND TREATMENT OF OSTEO ARTHRITIS - Google Patents

COMPOSITIONS FOR PREVENTION AND TREATMENT OF OSTEO ARTHRITIS

Info

Publication number
IT1392395B1
IT1392395B1 ITMI2008A002285A ITMI20082285A IT1392395B1 IT 1392395 B1 IT1392395 B1 IT 1392395B1 IT MI2008A002285 A ITMI2008A002285 A IT MI2008A002285A IT MI20082285 A ITMI20082285 A IT MI20082285A IT 1392395 B1 IT1392395 B1 IT 1392395B1
Authority
IT
Italy
Prior art keywords
prevention
compositions
treatment
osteo arthritis
osteo
Prior art date
Application number
ITMI2008A002285A
Other languages
Italian (it)
Inventor
Gabriella Calderoni
Paolo Tramonti
Cristiano Meggiato
Original Assignee
Bios Line Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bios Line Spa filed Critical Bios Line Spa
Priority to ITMI2008A002285A priority Critical patent/IT1392395B1/en
Publication of ITMI20082285A1 publication Critical patent/ITMI20082285A1/en
Application granted granted Critical
Publication of IT1392395B1 publication Critical patent/IT1392395B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/324Boswellia, e.g. frankincense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ITMI2008A002285A 2008-12-22 2008-12-22 COMPOSITIONS FOR PREVENTION AND TREATMENT OF OSTEO ARTHRITIS IT1392395B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI2008A002285A IT1392395B1 (en) 2008-12-22 2008-12-22 COMPOSITIONS FOR PREVENTION AND TREATMENT OF OSTEO ARTHRITIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2008A002285A IT1392395B1 (en) 2008-12-22 2008-12-22 COMPOSITIONS FOR PREVENTION AND TREATMENT OF OSTEO ARTHRITIS

Publications (2)

Publication Number Publication Date
ITMI20082285A1 ITMI20082285A1 (en) 2010-06-23
IT1392395B1 true IT1392395B1 (en) 2012-03-02

Family

ID=40999898

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2008A002285A IT1392395B1 (en) 2008-12-22 2008-12-22 COMPOSITIONS FOR PREVENTION AND TREATMENT OF OSTEO ARTHRITIS

Country Status (1)

Country Link
IT (1) IT1392395B1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494668A (en) * 1994-07-11 1996-02-27 Patwardhan; Bhushan Method of treating musculoskeletal disease and a novel composition therefor
US6224871B1 (en) * 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
US6780841B2 (en) * 2001-11-13 2004-08-24 Biocell Technology, Llc Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
US20060240037A1 (en) * 2003-06-04 2006-10-26 Edward Fey Methods and compositions for the treatment and prevention of degenerative joint disorders
KR20080049938A (en) * 2006-12-01 2008-06-05 가부시키가이샤 토우시츠 카가쿠 켄큐죠 Remedies for degenerative arthritis
CH704033B1 (en) * 2007-03-26 2012-05-15 Swiss Caps Rechte Und Lizenzen Ag Capsules containing herbal preparations.

Also Published As

Publication number Publication date
ITMI20082285A1 (en) 2010-06-23

Similar Documents

Publication Publication Date Title
SMT201500280B (en) NEW COMPOSITIONS TO PREVENT AND / OR TREAT DISORDERS FROM LYSOSOMIAL STORAGE
BRPI1011587A2 (en) therapeutic compounds and compositions
BRPI0911764A2 (en) cyclic inhibitors of 11betahydroxysteroid desigrogenase 1
HK1162352A1 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof -3-
EP2376126A4 (en) Antagonists of il-6 to prevent or treat thrombosis
IL197869A0 (en) Compositions of chk1 inhibitors
DK2419670T3 (en) METHOD OF DELIVERY AND COMPOSITIONS
DK2274008T3 (en) Compositions and Methods for Inhibition of PDGFRBETA and VEGF-A
DK2322221T3 (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF CANCER
BR112012001325A2 (en) treatment of liver disorders with pi3k inhibitors
PT2373681T (en) Pharmaceutical compositions of albiglutide
BR112012009574A2 (en) allosteric enhancer of mglura, compositions, and methods of treating neurological dysfunction
SMT201600332B (en) COMPOSITIONS AND METHODS FOR THE INCREASE OF THE TELOMERASICA ACTIVITY
SI2300614T1 (en) Methods and compositions for treatment of mitochondrial disorders
DK3300729T3 (en) THERAPEUTIC COMPOSITIONS CONTAINING MACITENTAN
EP2355657A4 (en) Compositions and methods of treating endothelial disorders
SMT201400165B (en) Compositions and methods for the treatment of multiple sclerosis
IL207724A0 (en) Cns pharmaceutical compositions and methods of use
SMT201600156B (en) TREATMENT OF OSTEOARTRITIS
EP2395980A4 (en) Compositions and methods for treating post-operative pain using bupivacaine and an anti-inflammatory agent
HK1162483A1 (en) Compositions and methods for inhibition of the jak pathway
SMT201500071B (en) Antimalarial agents that are inhibitors of dihydro-orotate dehydrogenase
SMT201500124B (en) Compositions of bisphosphonates and methods for the treatment of heart failure
IL210102A0 (en) Pharmaceutical compositions of rosuvastatin calcium
SMT201500123B (en) Unit dosage of apadenoson